Extra-adrenal pheochromocytoma: Diagnosis and management

Current Urology Reports

Volumn 8, Issue 1, 2007, Pages 83-88

  Disick, Grant I S ^a   Palese, Michael A ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PHENOXYBENZAMINE; PRAZOSIN; VINCRISTINE;

CANCER LOCALIZATION; CATECHOLAMINE URINE LEVEL; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; INTRAOPERATIVE PERIOD; LAPAROSCOPIC SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLION; PEROPERATIVE ECHOGRAPHY; PHEOCHROMOCYTOMA; PREOPERATIVE PERIOD; REVIEW; SCINTIGRAPHY; SURGICAL APPROACH; SWEATING;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PHEOCHROMOCYTOMA; RISK ASSESSMENT; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33846850572     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0025-5     Document Type: Review

References (38)

1. Welbourn R: Early surgical history of pheochromocytoma. Br J Surg 1987, 74:594-596.
2. Whalen RK, Althausen AF, Daniels GH: Extra-adrenal pheochromocytoma. J Urol 1993, 147:1-10.
3. Salanatri J, Smith P, Sclicht S: Multifocal malignant extra-adrenal paragangliomas of the organ of Zuckerkandl and urinary bladder. Austrasl Radiol 2001, 45:229-232.
4. Glenner GG, Grimley PM: Tumors of the extra-adrenal paraganglion system. In Atlas of Tumor Pathology (2nd series). Washington DC: Armed Forces Institute of Pathology; 1974.
5. Carney J, Sheps S, Go V, et al.: The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 1977, 296:1517-1518.
6. O'Riordain D, Young W, Grant C, et al.: Clinical spectrum and outcome of functional extradrenal paragangliomas. World J Surg 1996, 20:916-921.
7. Neumann H, Pawlu C, Peczkowska M, et al.: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004, 292:943-951.
8. Lenders J, Pacak K, Walther W, et al.: Biochemical diagnosis of pheochromocytomas: which test is best? JAMA 2002, 287:1427-1434.
9. •• Hwang JJ, Shoaf G, Uchio EM, et al.: Laparoscopic management of extra-adrenal pheochromocytoma. J Urol 2004, 171:72-76. Five patients with EAPs treated laparoscopically along with intraoperative ultrasound.
10. Yadav S, Singh SK, Sharma SK, et al.: Extra-adrenal pheochromocytoma: A cause of ureteral obstruction. J Urol 2000, 163:264.
11. Blecha M, Galanopolous C, Dharkar D, et al.: Massive organ of Zuckerkandl inducing small bowel obstruction. J Am Coll Surg 2005, 201:480-481.
12. Stevenson S, Ramani V, Nasim A, et al.: Extra-adrenal pheochromocytoma: an unusual cause of deep vein thrombosis. J Vasc Surg 2005, 42:570-572.
13. Alderazi Y, Yeh M, Robinson B, et al.: Phaeochromocytoma: current concepts. Med J Aust 2005, 183:201-204.
14. •• Ilias I, Pacak K: Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 2004, 89:479-491. Thorough review of imaging modalities available for pheochromocytomas and EAPs; extensive information on MIBG and PET scans.
15. Lee M, Mayo-Smith W, Hahn O: State of the art MR imaging of the adrenal gland. Radiographics 1984, 14:1015-1029.
16. Lumachi F, Tregnaghi A, Zucchetta P, et al.: Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study. Nucl Med Commun 2006, 27:583-587.
17. Brink I, Hoegerle S, Klisch J, et al.: Imaging of peochromocytoma and paraganglioma. Fam Cancer 2005, 4:61-68.
18. Fujita A, Hyodoh H, Kawamura Y, et al.: Use of fusion images of 1-131 metaiodobenzylguanidine, SPECT, and magnetic resonance studies to identify a malignant pheochromocytoma. Clin Nucl Med 2000, 25:440-442.
19. Ilias I, Yu J, Carrasquillo JA, et al.: Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]- metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 2003, 88:4083-4087.
20. Brunaud L, Bresler L, Zarnegar R, et al.: Does robotic adrenalectomy improve patient quality of life when compared to laparoscopic adrenalectomy? World J Surg 2004, 28:1180-1185.
21. Vargas H, Kavoussi L, Bartlett D, et al.: Laparoscopic adrenalectomy: a new standard of care. Urology 1997, 49:673-678,
22. Janetschek G, Finkenstedt G, Gasser R, et al.: Laparoscopic surgery for pheochromocytoma: adrenalectomy, partial resection, excision of paragangliomas. J Urol 1998, 160:330-334.
23. Lombardi C, Raffaelli M, De Crea C, et al.: Pheochromocytoma: role of preoperative diagnosis in the assessment of malignancy risk and in the choice of surgical approach. Suppl Tumori 2005, 4:S211.
24. Tagaya N, Suzuki N, Furihata T, et al.: Laparoscopic resection of a functional paraganglioma in the organ of Zuckerkandl. Surg Endosc 2002, 16:219.
25. Mithani SK, Marohn MR, Freischlag JA, et al.: Laparoscopic resection of a paraganglioma of the organ of Zuckerkandl in a patient with a carotid body tumor. Am Surg 2006, 72:55-59.
26. Walz M, Peitgen K, Neumann H, et al.: Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg 2002, 26:1005-1012.
27. Kercher KW, Heniford BT, Marroum MC, et al.: Laparoscopic intraoperative ultrasonic localization and resection of an extra-adrenal pheochromocytoma. J Laparoendosc Adv Surg Tech 1999, 9:511-515.
28. Goldfarb DA, Novick AC, Bravo EL, et al.: Experience with extra-adrenal pheochromocytoma. J Urol 1989, 142:931-936.
29. Scott H, Halter S: Oncologic aspects of pheochromocytomas: the importance of follow-up. Surgery 1984, 96:1061-1066.
30. Sclafani L, Woodruff J, Brennan M: Extraadrenal retroperitoneal paragangliomas: Natural history and response to treatment. Surgery 1990, 108:1124-1129.
31. Edstrom E, Hjelm S, Hoog A, et al.: The management of benign and malignant pheochromocytoma and abdominal paraganglioma. Eur J Surg Oncol 2003, 29:278-283.
32. Loh K, Fitzgerald P, Matthay K, et al.: The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 1997, 20:648-658.
33. Sisson J, Shapiro B, Shulkin B, et al.: Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy. Am J Clin Oncol 1999, 22:364-370.
34. Safford S, Coleman E, Gockerman J, et al.: 131I metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery 2003, 134:956-962.
35. Rose B, Matthay KK, Price D, et al.: High-dose 131I- metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 2003, 98:239-248.
36. Del Pizzo JJ: Radiofrequency ablation for adrenal lesions. Curr Urol Rep 2006, 7:68.
37. Ishak KG, Goodman ZD, Stocker JT: Tumors of the liver and intrahepatic bile ducts. In Atlas of Tumor Pathology, 3rd series, fascicle 31. Washington DC: Armed Forces Institute of Pathology; 2001:195-196.
38. Lack EE: Tumors of the Adrenal Gland and Extra-adrenal Paraganglia. In Atlas of Tumor Pathology, 3rd series, fascicle 19. Washington DC: Armed Forces Institute of Pathology; 1997:261.